NORTHPOINTE CAPITAL LLC - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 90 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2018. The put-call ratio across all filers is 1.39 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHPOINTE CAPITAL LLC ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q4 2018$602,000
-85.8%
562,761
-18.1%
0.14%
-77.7%
Q3 2018$4,227,000
-51.6%
687,287
-15.8%
0.61%
-47.3%
Q2 2018$8,725,000816,1401.16%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2018
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 169,629$147,5600.05%
BROWN WEALTH MANAGEMENT, LLC 110,000$95,6890.05%
Carmignac Gestion 2,132,744$1,855,2740.03%
WATER ISLAND CAPITAL LLC 82,500$720.01%
Northeast Financial Consultants Inc 83,000$72,2020.01%
XTX Topco Ltd 27,545$23,9610.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 175,600$152,7540.00%
Curi Wealth Management, LLC 25,000$21,7480.00%
Banque Cantonale Vaudoise 40,000$350.00%
SYNOVUS FINANCIAL CORP 58,071$50,5160.00%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders